PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

23 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Lin, J. et al.: Associations of proteomics with hypertension and systolic blood pressure: KORA S4/F4/FF4 and KORA-Age1/Age2 Cohort Studies. Hypertension 81, 1156-1166 (2024)
2.
Gong, S.* et al.: Primary aldosteronism: Spatial multi-omics mapping of genotype-dependent heterogeneity and tumor expansion of aldosterone-producing adenomas. Hypertension 80, 1555-1567 (2023)
3.
Thürmann, L.* et al.: Undiagnosed pediatric elevated blood pressure is characterized by induction of pro-inflammatory and cytotoxic mediators. Hypertension 80, 2425-2436 (2023)
4.
Vishram-Nielsen, J.K.K.* et al.: Predictive importance of blood pressure characteristics with increasing age in healthy men and women: The MORGAM Project. Hypertension 77, 1076-1085 (2021)
5.
Sun, N. et al.: Mass spectrometry imaging establishes 2 distinct metabolic phenotypes of aldosterone-producing cell clusters in primary aldosteronism. Hypertension 75, 634-644 (2020)
6.
Vishram-Nielsen, J.K.K.* et al.: Does estimated pulse wave velocity add prognostic information? MORGAM prospective cohort project. Hypertension 75, 1420-1428 (2020)
7.
Vohra, T.* et al.: Effect of dietary sodium modulation on pig adrenal steroidogenesis and transcriptome profiles. Hypertension 76, 1769-1777 (2020)
8.
Wain, L.V.* et al.: Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension 70, e4-e19 (2017)
9.
Zeller, T.* et al.: Transcriptome-wide analysis identifies novel associations with blood pressure. Hypertension 70, 713-750 (2017)
10.
Menni, C.* et al.: Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension 66, 422-429 (2015)
11.
Fernandes-Rosa, F.L.* et al.: Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64, 354-361 (2014)
12.
Spyroglou, A.* et al.: Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion. Hypertension 63, 1102-1109 (2014)
13.
Lieb, W.* et al.: Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension 61, 995-1001 (2013)
14.
Dreger, H.* et al.: Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells. Hypertension 60, 1176-1183 (2012)
15.
Mulatero, P.* et al.: KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension 59, 235-240 (2012)
16.
Reincke, M.* et al.: Observational study mortality in treated primary aldosteronism: The German Conn's registry. Hypertension 60, 618-624 (2012)
17.
Bähr, I.N.* et al.: High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome. Hypertension 58, 725-732 (2011)
18.
Tabara, Y.* et al.: Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: The Japanese millennium genome project. Hypertension 56, 973-980 (2010)
19.
Baessler, S.* et al.: Association of the Ghrelin receptor gene region with left ventricular hypertrophy in the general population: Results of the MONICA/KORA Augsburg echocardiographic substudy. Hypertension 47, 920-927 (2006)
20.
Mayer, B.* ; Döring, A. & Löwel, H.: Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension 46, 766-771 (2005)